Details for Patent: 8,927,540
✉ Email this page to a colleague
Which drugs does patent 8,927,540 protect, and when does it expire?
Patent 8,927,540 protects TEPMETKO and is included in one NDA.
This patent has seventy-six patent family members in thirty-five countries.
Summary for Patent: 8,927,540
| Title: | Pyridazinone derivatives |
| Abstract: | Compounds of the formula (I), in which R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.4', have the meanings indicated in Claim 1, are inhibitors of tyrosine kinases, in particular Met kinase, and can be employed, inter alia, for the treatment of tumors. |
| Inventor(s): | Dorsch; Dieter (Ober-Ramstadt, DE), Stieber; Frank (Heidelberg, DE), Schadt; Oliver (Rodenbach, DE), Blaukat; Andree (Muehltal, DE) |
| Assignee: | Merck Patent GmbH (Darmstadt, DE) |
| Application Number: | 13/785,580 |
|
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 8,927,540
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Emd Serono Inc | TEPMETKO | tepotinib hydrochloride | TABLET;ORAL | 214096-001 | Feb 3, 2021 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | TREATING A SOLID TUMOR, INCLUDING LUNG CANCER, HAVING A MET KINASE ALTERATION(S) BY ADMINISTERING AN EFFECTIVE AMOUNT OF TEPOTINIB | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 8,927,540
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| Germany | 10 2007 032 507 | Jul 12, 2007 |
International Family Members for US Patent 8,927,540
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 2164843 | ⤷ Sign Up | C02164843/01 | Switzerland | ⤷ Sign Up |
| European Patent Office | 2164843 | ⤷ Sign Up | 301176 | Netherlands | ⤷ Sign Up |
| European Patent Office | 2164843 | ⤷ Sign Up | PA2022009 | Lithuania | ⤷ Sign Up |
| European Patent Office | 2164843 | ⤷ Sign Up | 2022C/519 | Belgium | ⤷ Sign Up |
| European Patent Office | 2164843 | ⤷ Sign Up | LUC00264 | Luxembourg | ⤷ Sign Up |
| European Patent Office | 2164843 | ⤷ Sign Up | CA 2022 00021 | Denmark | ⤷ Sign Up |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
